Featured Press Releases

Qosina Introduces New iDOT™ Single-Use Sensor Bag Ports from Polestar Technologies

Qosina Introduces New iDOT™ Single-Use Sensor Bag Ports from Polestar Technologies

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

  • 28 Aug 2024

CVS Health® announced that the updated 2024-2025 COVID-19 vaccines and flu vaccines are available...

Prolacta Bioscience Leads in Human Milk Science, Regularly Reviewing Health Claims with FDA

Prolacta Bioscience Leads in Human Milk Science, Regularly Reviewing Health Claims with FDA

To advance the first oral therapy for BK Polyomavirus, Orthogon Therapeutics closes an oversubscribed $5.2M financing

To advance the first oral therapy for BK Polyomavirus, Orthogon Therapeutics closes an oversubscribed $5.2M financing

Chime Biologics Partners with Polpharma Biologics to Advance Global Biosimilar Development

Chime Biologics Partners with Polpharma Biologics to Advance Global Biosimilar Development

Datar Cancer Genetics will provide groundbreaking video-enhanced results of in-vitro chemotherapy effectiveness tests for cancer patients

Datar Cancer Genetics will provide groundbreaking video-enhanced results of in-vitro chemotherapy effectiveness tests for cancer patients

Spruce Biosciences Reports Long-Term Data Showing Efficacy and Safety of Tralesinidase Alfa in Sanfilippo Syndrome Type B

Spruce Biosciences Reports Long-Term Data Showing Efficacy and Safety of Tralesinidase Alfa in Sanfilippo Syndrome Type B

  • Spruce Biosciences, Inc.
  • 18 Aug 2025
Izalontamab Brengitecan Receives FDA Breakthrough Therapy Designation for Advanced EGFR-Mutated NSCLC

Izalontamab Brengitecan Receives FDA Breakthrough Therapy Designation for Advanced EGFR-Mutated NSCLC

  • SystImmune, Inc.
  • 18 Aug 2025
New Survey Shows Pediatricians Strongly Prefer Genexa’s Ingredients Over Leading Children’s Tylenol® Products

New Survey Shows Pediatricians Strongly Prefer Genexa’s Ingredients Over Leading Children’s Tylenol® Products

  • Genexa
  • 15 Aug 2025
Proving the strength of its drug-delivery platform, the Daewoong Therapeutics Microneedle Patch achieves best-in-class bioavailability

Proving the strength of its drug-delivery platform, the Daewoong Therapeutics Microneedle Patch achieves best-in-class bioavailability

  • Daewoong Therapeutics Inc
  • 13 Aug 2025
Abcentra LLC Commences Phase 2b

Abcentra LLC Commences Phase 2b 'FORTIFY' Trial with First Patient Dosed, Evaluating Orticumab for Cardiovascular Disease

  • Abcentra
  • 12 Aug 2025
Viatris announces the approval of the first generic iron sucrose injection in the U.S

Viatris announces the approval of the first generic iron sucrose injection in the U.S

  • Viatris Inc.
  • 11 Aug 2025
Webinar: Leverage AI for Operational Excellence and Strategic Cost Management

Most Popular
August   2025
M T W T F S S
        1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

User Area

Discover

Engage with Us

© 2024 Pharmaceutical Era — A product of HISSM. All Rights Reserved.